Authors:
Cherifi, S
Hermans, P
De Wit, S
Cantinieaux, B
Clumeck, N
Citation: S. Cherifi et al., Acute pulmonary hypertension following paclitaxel in a patient with AIDS-related primary effusion lymphoma, CL MICRO IN, 7(5), 2001, pp. 277-278
Citation: P. Hermans, Current review and clinical management of patients with primary HIV-1 infection: limits and perspectives, BIOMED PHAR, 55(6), 2001, pp. 301-307
Authors:
Simonart, T
Degraef, C
Mosselmans, R
Hermans, P
Lunardi-Iskandar, Y
Noel, JC
Van Vooren, JP
Parent, D
Heenen, M
Galand, P
Citation: T. Simonart et al., Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis, J INVES DER, 116(5), 2001, pp. 679-685
Authors:
Colebunders, R
Dohmen, S
Van de Velde, A
Pelgrom, J
Hermans, P
Citation: R. Colebunders et al., Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment, ACT CLIN B, 56(5), 2001, pp. 321-322
Authors:
Dargent, JL
Lespagnard, L
Kornreich, A
Hermans, P
Clumeck, N
Verhest, A
Citation: Jl. Dargent et al., HIV-associated multinucleated giant cells in lymphoid tissue of the Waldeyer's ring: A detailed study, MOD PATHOL, 13(12), 2000, pp. 1293-1299
Authors:
Van Laethem, K
Schmit, JC
Pelemans, H
Balzarini, J
Witvrouw, M
Perez-Perez, MJ
Camarasa, MJ
Esnouf, RM
Aquaro, S
Cenci, A
Perno, CF
Hermans, P
Sprecher, S
Ruiz, L
Clotet, B
Van Wijngaerden, E
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients, AIDS RES H, 16(9), 2000, pp. 825-833
Authors:
Van Vaerenbergh, K
Van Laethem, K
Van Wijngaerden, E
Schmit, JC
Schneider, F
Ruiz, L
Clotet, B
Verhofstede, C
Van Wanzeele, F
Muyldermans, G
Simons, P
Stuyver, L
Hermans, P
Evans, C
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Authors:
Maes, M
Vandoolaeghe, E
Degroote, J
Altamura, C
Roels, C
Hermans, P
Citation: M. Maes et al., Linear CT-scan measurements in alcohol-dependent patients with and withoutdelirium tremens, ALCOHOL, 20(2), 2000, pp. 117-123
Authors:
Van Laethem, K
Witvrouw, M
Balzarini, J
Schmit, JC
Sprecher, S
Hermans, P
Leal, M
Harrer, T
Ruiz, L
Clotet, B
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir, AIDS, 14(4), 2000, pp. 469-471
Authors:
Jones, PT
Hermans, P
Blanpain, B
Wollants, P
Citation: Pt. Jones et al., Optimization of an accurate and precise analysis procedure for metallurgical VOD slags with ICP-OES, ATOM SPECT, 21(3), 2000, pp. 86-92
Authors:
Simonart, T
Degraef, C
Andrei, G
Mosselmans, R
Hermans, P
Van Vooren, JP
Noel, JC
Boelaert, JR
Snoeck, R
Heenen, M
Citation: T. Simonart et al., Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors, J INVES DER, 115(5), 2000, pp. 893-900
Authors:
Simonart, T
Hermans, P
Schandene, L
Van Vooren, JP
Citation: T. Simonart et al., Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature, BR J DERM, 143(3), 2000, pp. 557-563
Authors:
Van Laethem, K
Van Vaerenbergh, K
Schmit, JC
Sprecher, S
Hermans, P
De Vroey, V
Schuurman, R
Harrer, T
Witvrouw, M
Van Wijngaerden, E
Stuyver, L
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Authors:
Gringeri, A
Musicco, M
Hermans, P
Bentwich, Z
Cusini, M
Bergamasco, A
Santagostino, E
Burny, A
Bizzini, B
Zagury, D
Citation: A. Gringeri et al., Active anti-interferon-alpha immunization: A European-Israeli, randomized,double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study), J ACQ IMM D, 20(4), 1999, pp. 358-370
Authors:
Zagury, D
Lecoq, H
Gervi, I
Le Buanec, H
Zagury, JF
Bizzini, B
Burny, A
Hermans, P
Perja, M
Santagostino, E
Gringeri, A
Citation: D. Zagury et al., Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy, BIOMED PHAR, 53(2), 1999, pp. 90-92
Authors:
De Wit, S
Cassano, P
Hermans, P
Kabeya, K
Gerard, M
O'Doherty, E
Clumeck, N
Citation: S. De Wit et al., Salvage therapy with ritonavir-saquinavir plus two nucleoside reverse transcriptase inhibitors in patients failing with amprenavir-zidovudine-lamivudine, AIDS, 13(7), 1999, pp. 864-865
Authors:
De Wit, S
Cassano, P
Hermans, P
Sommereijns, B
Kabeya, K
O'Doherty, E
Clumeck, N
Citation: S. De Wit et al., Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, ritonavir or saquinavir, AIDS, 13(13), 1999, pp. 1794-1795
Authors:
De Thier, F
Simonart, T
Hermans, P
Andre, J
Van Vooren, JP
Noel, JC
Citation: F. De Thier et al., Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction, AM J DERMAT, 21(1), 1999, pp. 25-27
Authors:
Langedijk, AC
Spinelli, S
Anguille, C
Hermans, P
Nederlof, J
Butenandt, J
Honegger, A
Cambillau, C
Pluckthun, A
Citation: Ac. Langedijk et al., Insight into odorant perception: The crystal structure and binding characteristics of antibody fragments directed against the musk odorant traseolide, J MOL BIOL, 292(4), 1999, pp. 855-869